Hyperion Asset Management Ltd Sells 7,447 Shares of Axon Enterprise, Inc $AXON

Hyperion Asset Management Ltd cut its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 3.4% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 213,509 shares of the biotechnology company’s stock after selling 7,447 shares during the period. Axon Enterprise accounts for about 3.2% of Hyperion Asset Management Ltd’s investment portfolio, making the stock its 14th biggest holding. Hyperion Asset Management Ltd owned 0.26% of Axon Enterprise worth $119,695,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. raised its stake in shares of Axon Enterprise by 0.6% during the 4th quarter. Vanguard Group Inc. now owns 9,367,224 shares of the biotechnology company’s stock worth $5,319,928,000 after purchasing an additional 53,060 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Axon Enterprise by 1.6% in the fourth quarter. Geode Capital Management LLC now owns 2,226,159 shares of the biotechnology company’s stock valued at $1,265,657,000 after purchasing an additional 35,544 shares during the last quarter. Sands Capital Management LLC boosted its holdings in shares of Axon Enterprise by 11.6% during the fourth quarter. Sands Capital Management LLC now owns 1,609,436 shares of the biotechnology company’s stock worth $914,047,000 after acquiring an additional 167,095 shares during the period. Wellington Management Group LLP boosted its holdings in shares of Axon Enterprise by 326.9% during the fourth quarter. Wellington Management Group LLP now owns 1,539,738 shares of the biotechnology company’s stock worth $874,463,000 after acquiring an additional 1,179,038 shares during the period. Finally, Edgewood Management LLC bought a new stake in shares of Axon Enterprise during the fourth quarter worth approximately $846,516,000. 79.08% of the stock is currently owned by institutional investors.

More Axon Enterprise News

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Earnings beat supports the rally: Axon reported quarterly earnings of $1.88 per share versus the $1.84 consensus estimate, while revenue of $904.4 million exceeded expectations of $876.4 million. Revenue increased 35.3% year over year, reinforcing the company’s strong demand across connected public-safety hardware and software. Axon Jumps After Earnings Beat and Analyst Target Hikes
• Positive Sentiment: Analyst support and future catalysts: Analyst target increases and the post-earnings rebound have improved sentiment, with investors awaiting the next potential growth catalyst. The company’s expanding product ecosystem and strong top-line growth remain central to the bullish case. Analyst Target Hikes and Next Catalyst
• Neutral Sentiment: Short-interest data provides no signal: Reported short interest was zero shares, with a zero-day days-to-cover ratio. Because the figures show no meaningful short position, they are unlikely to explain the stock’s move or provide useful evidence of future buying pressure.
• Negative Sentiment: Valuation remains demanding: Commentary highlights Axon’s strong growth but also its high valuation, while another analyst downgraded the stock and suggested taking some profits. The shares trade at a very high earnings multiple, leaving them vulnerable if growth or profitability disappoints. Axon Rating Downgrade
• Negative Sentiment: Margin pressure and insider selling temper enthusiasm: Investors remain focused on memory costs and counter-drone hardware expenses, which may constrain margins as Axon invests for growth. CEO Patrick W. Smith also sold approximately $5.5 million of shares under a pre-arranged Rule 10b5-1 plan, though the sale represented only about 0.33% of his holdings.

Axon Enterprise Stock Up 6.7%

NASDAQ AXON opened at $636.31 on Wednesday. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47. The company has a market cap of $51.69 billion, a price-to-earnings ratio of 264.03, a PEG ratio of 12.17 and a beta of 1.39. The company has a 50 day moving average of $519.11 and a 200-day moving average of $473.46. Axon Enterprise, Inc has a 1-year low of $339.01 and a 1-year high of $824.66.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.84 by $0.04. The business had revenue of $904.39 million for the quarter, compared to the consensus estimate of $876.42 million. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%.The firm’s quarterly revenue was up 35.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.12 earnings per share. On average, equities research analysts expect that Axon Enterprise, Inc will post 1.63 earnings per share for the current fiscal year.

Insider Activity at Axon Enterprise

In related news, CEO Patrick W. Smith sold 9,930 shares of the firm’s stock in a transaction on Friday, August 7th. The stock was sold at an average price of $548.77, for a total value of $5,449,286.10. Following the transaction, the chief executive officer owned 3,031,067 shares in the company, valued at approximately $1,663,358,637.59. This trade represents a 0.33% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Caitlin Elizabeth Kalinowski sold 564 shares of the business’s stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $478.97, for a total value of $270,139.08. Following the completion of the transaction, the director directly owned 3,632 shares of the company’s stock, valued at approximately $1,739,619.04. This trade represents a 13.44% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 68,989 shares of company stock worth $36,016,932 in the last quarter. 4.20% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on AXON shares. Weiss Ratings reiterated a “hold (c-)” rating on shares of Axon Enterprise in a research note on Wednesday, August 5th. Barclays upped their price objective on Axon Enterprise from $523.00 to $688.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. The Goldman Sachs Group reiterated a “buy” rating and set a $715.00 price objective on shares of Axon Enterprise in a research report on Thursday, August 6th. Citizens Jmp reissued a “market outperform” rating and issued a $700.00 target price on shares of Axon Enterprise in a research report on Thursday, June 25th. Finally, Piper Sandler upped their price target on shares of Axon Enterprise from $724.00 to $732.00 and gave the company an “overweight” rating in a research note on Thursday, August 6th. Thirteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, Axon Enterprise currently has a consensus rating of “Moderate Buy” and an average price target of $730.92.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.